Cybin Financials
| CYBN Stock | USD 10.04 0.28 2.71% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 23.32 | 21.6458 |
|
|
Investors should never underestimate Cybin's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Cybin's cash flow, debt, and profitability to make informed and accurate decisions about investing in Cybin Inc.
Net Income |
|
Cybin | Select Account or Indicator |
Understanding current and past Cybin Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cybin's financial statements are interrelated, with each one affecting the others. For example, an increase in Cybin's assets may result in an increase in income on the income statement.
Cybin Stock Summary
Cybin competes with Mind Medicine, GH Research, ATAI Life, Fortress Biotech, and Bio Path. Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. It has also developed EMBARK, a psychedelic-assisted psychotherapy. Cybin operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 50 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NYSE MKT Exchange |
| ISIN | CA23256X1006 |
| CUSIP | 23256X100 23256X407 |
| Location | Ontario; Canada |
| Business Address | 100 King Street |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cybin.com |
| Phone | 908 764 8385 |
| Currency | USD - US Dollar |
Cybin Key Financial Ratios
| Return On Equity | -0.49 | ||||
| Price To Sales | 278.25 X | ||||
| Gross Profit | (311 K) | ||||
| EBITDA | (78.58 M) | ||||
| Net Income | (78.08 M) |
Cybin Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Current Assets | 1.1M | 1.3M | 4.7M | 6.6M | 9.5M | 10.0M |
Cybin Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Operating Income | (2.0M) | (30.5M) | (63.6M) | (54.9M) | (78.8M) | (74.9M) | |
| Ebitda | 9.6K | (32.2M) | (63.7M) | (51.3M) | (78.6M) | (74.6M) | |
| Income Before Tax | (1.9M) | (32.2M) | (67.6M) | (47.5M) | (78.1M) | (74.2M) | |
| Net Income | (1.9M) | (32.2M) | (71.4M) | (40.0M) | (78.1M) | (74.2M) |
Cybin Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cybin's current stock value. Our valuation model uses many indicators to compare Cybin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cybin competition to find correlations between indicators driving Cybin's intrinsic value. More Info.Cybin Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Cybin's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cybin's earnings, one of the primary drivers of an investment's value.Cybin Inc Systematic Risk
Cybin's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cybin volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Cybin Inc correlated with the market. If Beta is less than 0 Cybin generally moves in the opposite direction as compared to the market. If Cybin Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cybin Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cybin is generally in the same direction as the market. If Beta > 1 Cybin moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Cybin Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cybin's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cybin growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Cybin December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cybin help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cybin Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cybin Inc based on widely used predictive technical indicators. In general, we focus on analyzing Cybin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cybin's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.26 | |||
| Information Ratio | 0.0843 | |||
| Maximum Drawdown | 24.94 | |||
| Value At Risk | (7.40) | |||
| Potential Upside | 9.3 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cybin Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cybin. If investors know Cybin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cybin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.03) | Return On Assets (0.33) | Return On Equity (0.49) |
The market value of Cybin Inc is measured differently than its book value, which is the value of Cybin that is recorded on the company's balance sheet. Investors also form their own opinion of Cybin's value that differs from its market value or its book value, called intrinsic value, which is Cybin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cybin's market value can be influenced by many factors that don't directly affect Cybin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cybin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cybin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cybin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.